A new technique has been recently developed by interventional radiologists to fight against obesity. The technique, known as bariatric arteriale embolization or BAE, is turning out to be a minimally invasive substitute for gastric bypass and other weight-loss related surgeries.
The pilot trial of BAE involved seven obese patients. Cheryl Denby was one of them. The 48-year-old had tried all the other means lose weight. But, failing in all her attempts, she kept on adding weight and started facing severe health concerns due to her growing weight.
However, after enrolling into BAE pilot project, Denby successfully lost 30 pounds of weight within the first three months. During the BAE procedure, a catheter was threaded by interventional radiologists through the wrist or groin to particular blood vessels that are located in a specific region of the stomach. After arriving at their target, the radiologists inserted microscopic beads to create a barrier for blood supply to this particular location where ghrelin, the hunger hormone of the body, is produced.
The cut in supply of blood to this spot results in an 80% reduction in hunger. Over a period of decades, the beads that are injected into blood vessels have been used in heart and uterine procedures safely. The initial outcomes of this procedure were presented by Dr. Clifford Weiss, the Director of the Johns Hopkins Center for Bioengineering Innovation and Design, at the annual meet of the Society of Interventional Radiology.
“This is essentially designed to be an outpatient procedure that takes under an hour with very little recovery time and very high safety profile. In our patients, we saw 6% weight loss at one month, 9.5% weight loss of 3 months and 13% weight loss at 6 months,” said Weiss.
A detailed weight management program is also offered to the patients to understand the new lifestyle and dietary approach.
In a report published by the Medical Daily, “Presenting their preliminary findings at the Society of Interventional Radiology’s 2016 Annual Scientific Meeting this week, the team reported that the nonsurgical treatment, coined bariatric arterial embolization (BAE), led to a reduction in the appetite and weight of five relatively healthy patients living with morbid obesity, all while having no major side effects. Three months after the procedure, patients had on average lost 5.9 percent of their excess weight; at 6 months, that expanded to 13.3 percent. A similar trend was seen in their levels of ghrelin, a hormone known to stir up our hunger.”
“These early results demonstrate that BAE appears to be effective in helping patients lose a significant amount of weight in the short and intermediate term,” said lead researcher Dr. Clifford Weiss, an associate professor of radiology and radiological science and director of interventional radiology research at Johns Hopkins, in a statement. “Compared to a surgical gastric bypass procedure, BAE is significantly less invasive and has a much shorter recovery time.”
“A procedure long used to halt stomach bleeding may offer another way to treat severe obesity, a preliminary study suggests,” according to a news report published by Chicago Tribune.
The study, of seven severely obese adults, found that the minimally invasive procedure caused no serious complications. It also spurred some weight loss: Patients lost 13 percent of their excess weight, on average, over the next six months.
According to a report in NBC NEWS by Morgan Radford, ” Cheryl Denby had tried everything to lose weight. But by age 48, she was becoming more obese, miserable and her weight had started to cause her major health problems.”
“I was in pain most days, my back, my knees, and it was hard to do daily things like laundry, grocery store, just getting up to get dressed.” said Denby. “I used to joke with my friend I just want to be able to tie my shoes without cutting off my air supply. That was a big deal, so I was unhappy.”
New Weight Loss Technique Bariatric Arteriale Embolization Registers Impressive Results
Keine Kommentare:
Kommentar veröffentlichen